Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Research Square|April 25, 2024
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for NeuroblastomaLi Che-Hsing, Sandhya Sharma, Andras A Heczey, et al.
Cytotherapy|July 6, 2024
International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges facedAshish O Gupta, Melissa Azul, Senthil Velan Bhoopalan, et al.
Blood|October 31, 2008
Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patientsChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Nature Medicine|February 17, 2025
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastomaChe-Hsing Li, Sandhya Sharma, Andras A Heczey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinomaChrystal U Louis, Karin Straathof, Catherine M Bollard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with NeuroblastomaAndras Heczey, Chrystal U Louis, Barbara Savoldo, et al.
Cytotherapy|May 1, 2010
Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experienceConrad Russell Cruz, Patrick J Hanley, Hao Liu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 23, 2014
Phase 1 study of intratumoral Pexa-Vec (JX-594), an oncolytic and immunotherapeutic vaccinia virus, in pediatric cancer patientsTimothy P Cripe, Minhtran C Ngo, James I Geller, et al.
Blood|October 11, 2011
Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastomaChrystal U Louis, Barbara Savoldo, Gianpietro Dotti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2018
Dual Inhibition of IGF-1R and ErbB3 Enhances the Activity of Gemcitabine and Nab-Paclitaxel in Preclinical Models of Pancreatic CancerAdam J Camblin, Emily A Pace, Sharlene Adams, et al.
Pageof 4